Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept + mFOLFOX6 in 1st-line mCRC
NCT00851084Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2009
- Primary completion
- Apr 2011
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 7
01
Overview
A Phase 2 trial of aflibercept in metastatic colorectal cancer (mCRC), sponsored by Sanofi. Started Feb 2009; status: completed.
02
Drugs
aflibercept
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00851084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851084.